Clinical studies with a new, low-dose oral contraceptive combination, containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol
Acta obstetricia et gynecologica Scandinavica. Supplement 144: 1-44
1987
ISSN/ISBN: 0300-8835 PMID: 2964165 Document Number: 291534
Document emailed within 1 workday
Related Documents
Yang, Z.-J.; Ye, W.-S.; Cui, G.-H.; Guo, Y.; Xue, S.-P. 2004: Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men Contraception 70(3): 203-211van den Ende, A.; Lütjens, A.; van Wayjen, R.G.; Kloosterboer, H.J. 1987: Effects of the Oral Contraceptive Combination 0.150 mg Desogestrel Plus 0.020 mg Ethinylestradiol on Carbohydrate Metabolism in Healthy Female Volunteers Acta Obstetricia et Gynecologica Scandinavica 66(s 143): 29-32
Tuimala, R.; Saranen, M.; Alapiessa, U. 1987: A Clinical Comparison in Finland of two Oral Contraceptives Containing 0.150 mg Desogestrel in Combination with 0.020 mg or 0.030 mg Ethinylestradiol Acta Obstetricia et Gynecologica Scandinavica 66(s 143): 7-12
Bilotta, P.; Favilli, S. 1988: Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive Arzneimittel-Forschung 38(7): 932-934
Endrikat, J.; Jaques, M.A.; Mayerhofer, M.; Pelissier, C.; Müller, U.; Düsterberg, B. 1995: A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance Contraception 52(4): 229-235
Rubio-lotvin, B.; Ruiz-moreno, J.A.; Gonzalez-ansorena, R. 1992: Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience Advances in Contraceptive Delivery Systems: Cds 8(1-2): 75-88
Burness, C.B. 2015: Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): a Review of its use as an Oral Contraceptive Drugs 75(9): 1019-1026
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Rákóczi, I.; Gerö, G.; Demeter, J.; Gáti, I. 1985: Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance Arzneimittel-Forschung 35(3): 630-633
Dieben, T.O.; van Beek, A.; Coelingh Bennink, H.J. 1991: Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight Arzneimittel-Forschung 41(9): 996-998
Ramamoorthy, R.; Saraswathi, T.P.; Kanaka, T.S. 1989: Carbohydrate metabolic studies during twelve months of treatment with a low-dose combination oral contraceptive Contraception 40(5): 563-569
Hendrix, S.L.; Alexander, N.J. 2002: Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive Contraception 66(6): 393-399
Taniguchi, F.; Enatsu, A.; Ota, I.; Toda, T.; Arata, K.; Harada, T. 2015: Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma European Journal of Obstetrics Gynecology and Reproductive Biology 191: 116-120
Heskamp, M.-L.S.; Schramm, G.A.K. 2010: Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits Contraception 81(1): 49-56
Anzai, Y.; Heger-Mahn, D.; Schellschmidt, I.; Marr, J. 2012: Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women Contraception 86(1): 28-34
Pandey, H.; Arjuman, A.; Roy, K.K.; Chandra, N.C. 2011: Reciprocal coordination of a combination oral contraceptive containing desogestrel+ethinyl estradiol on the expression of LOX-1 and LDLR in placental trophoblast cells Contraception 84(6): E43-E49
Sobbrio, G.A.; Granata, A.; D'Arrigo, F.; Arena, D.; Trimarchi, F.; Granese, D.; Pullè, C. 1989: Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel Acta Europaea Fertilitatis 20(1): 35-37
Kallio, H.; Rhen, K. 1978: The contraceptive effects of a new low-dose combination type oral contraceptive Current Medical Research and Opinion 5(6): 444-449
Kallio, H.; Rhen, K. 1978: The contraceptive effects of a new low-dose combination type oral contraceptive Current Medical Research and Opinion 5(6): 444-449
Caruso, S.; Agnello, C.; Intelisano, G.; Farina, M.; Di Mari, L.; Cianci, A. 2004: Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene Contraception 69(3): 237-240